Dopamine receptor type 2 (<scp>DRD2</scp>) and somatostatin receptor type 2 (<scp>SSTR2</scp>) agonists are effective in inhibiting proliferation of progenitor/stem‐like cells isolated from nonfunctioning pituitary tumorsErika Peverelli, Giovanna Mantovani|International Journal of Cancer|2017Cited by 60
A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A PhosphorylationFederica Mangili, Giovanna Mantovani|Frontiers in Endocrinology|2021Cited by 14